Our Specialist Nurses 0800 074 8383

Prostate biopsy results: PIN and ASAP

Download

This fact sheet is for men who've been diagnosed with high grade prostate intraepithelial neoplasia (PIN) or atypical small acinar proliferation (ASAP) after having a prostate biopsy. It explains what PIN and ASAP are and how they might be monitored.

Last updated: May 2019
To be reviewed: May 2022

References  

  • Ben-Shlomo, Y. et al. The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur. Urol. 53, 99–105 (2008).
  • Bostwick, D. G. & Cheng, L. Precursors of prostate cancer: Precursors of prostate cancer. Histopathology 60, 4–27 (2012).
  • Clouston, D. & Bolton, D. In situ and intraductal epithelial proliferations of prostate: Definitions and treatment implications Part 1: Prostatic intraepithelial neoplasia. BJU international 109, 22–26 (2012).
  • Clouston, D. & Bolton, D. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate. BJU Int. 110 Suppl 4, 22–24 (2012).
  • Cui, K. et al. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison. Oncotarget 8, 36674–36684 (2017).
  • De Marzo, A. M., Haffner, M. C., Lotan, T. L., Yegnasubramanian, S. & Nelson, W. G. Premalignancy in Prostate Cancer: Rethinking What We Know. Cancer Prevention Research 9, 648–656 (2016).
  • Dickinson, S. I. Premalignant and malignant prostate lesions: pathologic review. Cancer Control 17, 214–222 (2010).
  • Elkoushy, M. A., Elshal, A. M. & Elhilali, M. M. Incidental Prostate Cancer Diagnosis During Holmium Laser Enucleation: Assessment of Predictors, Survival, and Disease Progression. Urology 86, 552–557 (2015).
  • Kowalewski, A., Szylberg, Ł., Skórczewska, A. & Marszałek, A. Diagnostic Difficulties With Atrophy, Atypical Adenomatous Hyperplasia, and Atypical Small Acinar Proliferation: A Systematic Review of Current Literature. Clinical Genitourinary Cancer 14, 361–365 (2016).
  • Laurila, M. et al. Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer. European Journal of Cancer 46, 3068–3072 (2010).
  • Leone, A. et al. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer and Prostatic Diseases 19, 68–71 (2016).
  • Lloyd, T. et al. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Medicine 13, (2015).
  • Merrimen, J. L. O., Evans, A. J. & Srigley, J. R. Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia: Pathology 45, 251–263 (2013).
  • Montironi, R., Mazzucchelli, R., Lopez-Beltran, A., Scarpelli, M. & Cheng, L. Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance. BJU International 108, 1394–1401 (2011).
  • Mottet N et al. EAU - ESTRO - ESUR - SIOG Guidelines on Prostate Cancer. (2018).
  • National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management (update). Draft for consultation, December 2018.
  • Public Health England. Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing. (2016).
  • Wobker, S. E. & Epstein, J. I. Differential Diagnosis of Intraductal Lesions of the Prostate. [Review]. Journal of Surgical Pathology 40, e67-82 (2016).
  • Zynger, D. L. & Yang, X. High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer. International journal of clinical and experimental pathology 2, 327 (2009).

Share publication with others

Download digital versions of this publication

Download PDF 254.1KB